| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |